NRAS and neoplasm: For a few variants, however, including NRAS Q22K and CDK4 R24C, and the MAFs in ctDNA, were higher or equivalent to the MAFs in tumor tissue, suggesting the subclonal expression of these mutations in the lesion sequenced.